Alexandria Real Estate Equities
ARE
#2130
Rank
A$13.26 B
Marketcap
A$76.52
Share price
-1.05%
Change (1 day)
-48.67%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Earnings for Alexandria Real Estate Equities (ARE)

Earnings in 2025 (TTM): -A$19.73 Million

According to Alexandria Real Estate Equities 's latest financial reports the company's current earnings are A$2.97 Billion. In 2024 the company made an earning of A$0.99 Billion, an increase over its 2023 earnings that were of A$0.50 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alexandria Real Estate Equities from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$19.73 Million-101.98%
2024 A$0.99 B96.11%
2023 A$0.50 B-53.56%
2022 A$1.09 B-3.96%
2021 A$1.13 B-20.26%
2020 A$1.42 B72.88%
2019 A$0.82 B3.11%
2018 A$0.80 B73.54%
2017 A$0.46 B464.88%
2016 A$81.62 M-77.32%
2015 A$0.35 B36.31%
2014 A$0.26 B-10.81%
2013 A$0.29 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$16.92 B-57,124.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$32.13 B-108,373.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$11.77 B-39,765.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$14.11 B-47,665.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$1.42 B-4,887.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$11.47 B-38,749.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$0.18 B-727.01%๐Ÿ‡บ๐Ÿ‡ธ USA